Mantell Associates

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting immunological and inflammatory (I&I) conditions. Read more below: https://lnkd.in/ecAQ_u7r #biotechnews #bispecifics #biotech

Last Friday our Q4 top performers celebrated with our quarterly Lunch Club in London! It was a great afternoon starting with an amazing lunch at Hutong at the Shard, followed by crazy golf, pool and arcade games at Plonk! Huge congrats to everyone who qualified, well deserved - Ewan Rennison, Thomas White, Fernand Desjarlais, Conor O'Shea, Georgia Read, Annelesse Giles, Aaron Dudley, Robin Mantell, Tom Bryan and Siobhan McLoughlin. Our Lunch Club is designed to celebrate success and spend time out of the office as a team - well done everyone, we're already looking forward to the next one! #recruitmentlondon #recruitmentincentives #incentives

Axplora, a global CDMO for API small molecule and ADC manufacturing, is investing €50 million in its Mourenx site in Southwest France. Specializing in large-scale API industrial chemistry and chromatography, this project will enhance Mourenx’s capabilities, positioning it as a center of excellence in the Axplora network for contract manufacturing of APIs and drug substances for FDA-approved biologics. Read more below: https://lnkd.in/eJ83Z5Q2 #smallmolecule #api #cdmo

Novartis has agreed to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical company with abelacimab, a late-stage medicine in development for the prevention of stroke and systemic embolism in patients with atrial fibrillation. Read more below: https://lnkd.in/epMd327v #therapeutics #pharmanews #cdmonews

Don't just listen to us, listen to what our clients and candidates have to say! A fantastic testimonial for Millie Bone, Associate here at Mantell Associates. "Mantell Associates did an outstanding job in helping me find a new role. Their team is professional, dedicated, and truly invested in their candidates’ success. A special shoutout to Millie, who was an incredible recruiter. She was supportive, communicative, and genuinely cared about finding the right fit for me. I really appreciate all her effort, and I’m grateful for the opportunity she helped me secure. I’d highly recommend Mantell Associates to anyone looking for a new job!" Contact Millie on +44 (0)20 3854 7700. #testimonialtuesday #testimonial #pharmarecruitment

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease drugmaker appears to have attracted the attention of Merck KGaA, Darmstadt, Germany. Read more below: https://lnkd.in/emaikegS #raredisease #biopharma #cancerdrugs

Today we welcomed Isobel Hills to the MA London team! Isobel joins us as a Consultant, and will be focusing on the Diagnostics space across Europe and the US. She brings previous experience recruiting, and we look forward to her impact here at Mantell Associates. Welcome! #recruitmentlondon #welcome #lifesciencerecruitment

Gil Roth, President of the Pharma & Biopharma Outsourcing Association, shared his insights in the CPHI Annual Report 2024, highlighting the key challenges the outsourcing industry may face as it heads into 2025. Read more below: https://lnkd.in/e2sxJaiy #cdmo #cdmo2025 #cphi

Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO with facilities in Belgium, Spain, the Netherlands, and Sweden, has completed its acquisition of Catalent Pharma Solutions’ drug product manufacturing facility in Somerset, New Jersey. Read more below: https://lnkd.in/eMi32uH4 #drugproduct #pharmamanufacturing #cdmo

New opportunity! CFO - Pharma - Switzerland. Mantell Associates is currently partnered with a leading pharmaceutical manufacturing organisation who is searching for a CFO to join their leadership team and drive the company forward. Apply for this role online - https://lnkd.in/gdFRMzpX - or contact Conor O'Shea on +44 (0)20 3854 7700. #financejobs #cfo #clevel